Semaglutide (Ozempic) Market: Navigating The Patent Cliff And Strategic Implications
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Estimates and Forecast Timeline
1.3. Research Methodology
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Data Visualization
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. List of Secondary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Semaglutide (Ozempic) Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
3.3.4. Pricing Analysis
Chapter 4. Semaglutide (Ozempic) Market: Regional Estimates & Trend Analysis
4.1. Regional Market Share Analysis, 2024 & 2033
4.2. Regional Market Dashboard
4.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
4.4. North America
4.5. Europe
4.6. Asia Pacific
4.7. Latin America
4.8. Middle East and Africa
Chapter 5. Competitive Landscape
5.1. Company Profile
5.1.1. Novo Nordisk
5.1.1.1. Overview
5.1.1.2. Financial Performance
5.1.1.3. Strategic Mapping
5.2. Concurrent Competitive Landscape
5.2.1. Eli Lilly
5.2.1.1. Overview
5.2.1.2. Financial Performance
5.2.1.3. Product Benchmarking
5.2.1.4. Strategic Mapping
5.2.2. Viking Therapeutics
5.2.2.1. Overview
5.2.2.2. Financial Performance
5.2.2.3. Product Benchmarking
5.2.2.4. Strategic Mapping
5.2.3. Lexicon Pharmaceuticals
5.2.3.1. Overview
5.2.3.2. Financial Performance
5.2.3.3. Product Benchmarking
5.2.3.4. Strategic Mapping
5.2.4. Biocon
5.2.4.1. Overview
5.2.4.2. Financial Performance
5.2.4.3. Product Benchmarking
5.2.4.4. Strategic Mapping
5.2.5. AstraZeneca
5.2.5.1. Overview
5.2.5.2. Financial Performance
5.2.5.3. Product Benchmarking
5.2.5.4. Strategic Mapping
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Semaglutide (Ozempic) market, by region, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Semaglutide (Ozempic) market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Indication outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Semaglutide (Ozempic) market dynamics
Fig. 12 Semaglutide (Ozempic) market: Porter’s five forces analysis
Fig. 13 Semaglutide (Ozempic) market: PESTLE analysis
Fig. 14 Semaglutide (Ozempic) market revenue, by region
Fig. 15 Regional marketplace: Key takeaways
Fig. 16 North America Semaglutide (Ozempic) market, 2021 - 2033 (USD Million)
Fig. 17 Europe Semaglutide (Ozempic) market, 2021 - 2033 (USD Million)
Fig. 18 Asia Pacific Semaglutide (Ozempic) market, 2021 - 2033 (USD Million)
Fig. 19 Latin America Semaglutide (Ozempic) market, 2021 - 2033 (USD Million)
Fig. 20 MEA Semaglutide (Ozempic) market, 2021 - 2033 (USD Million)
Fig. 21 Company categorization
Fig. 22 Company market position analysis
Fig. 23 Strategic framework
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
Trusted market insights - try a free sample
See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.
